Discovery of Novel Pyrimidine-Based Derivatives as Nav1.2 Inhibitors with Efficacy in Mouse Models of Epilepsy.

MLA

He, Guoxue, et al. “Discovery of Novel Pyrimidine-Based Derivatives as Nav1.2 Inhibitors with Efficacy in Mouse Models of Epilepsy.” Journal of Medicinal Chemistry, vol. 67, no. 15, Aug. 2024, pp. 12912–31. EBSCOhost, https://doi.org/10.1021/acs.jmedchem.4c00861.

APA

He, G., Zheng, Y., Chang, S., Wang, L., Yang, X., Hao, H., Li, J., Zhang, X., Tian, F., Liang, X., Xu, H., Wang, P., Chen, X., Cao, Z., Fang, S., Gao, Z., & Liu, H. (2024). Discovery of Novel Pyrimidine-Based Derivatives as Nav1.2 Inhibitors with Efficacy in Mouse Models of Epilepsy. Journal of Medicinal Chemistry, 67(15), 12912–12931. https://doi.org/10.1021/acs.jmedchem.4c00861

Chicago

He, Guoxue, Yueming Zheng, Shunzhen Chang, Long Wang, Xiaohao Yang, Haishuang Hao, Jiyuan Li, et al. 2024. “Discovery of Novel Pyrimidine-Based Derivatives as Nav1.2 Inhibitors with Efficacy in Mouse Models of Epilepsy.” Journal of Medicinal Chemistry 67 (15): 12912–31. doi:10.1021/acs.jmedchem.4c00861.